Doxorubicin is a DSB‐inducing radiomimetic agent and is widely used as a cytotoxic drug in cancer treatment [11, 30], but its retention in cells is also influenced by the expression of membrane efflux pumps such as ABCG2. Here, ABCG2 is linked to cancer.